These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 5553941)
21. [Treatment of Parkinson's syndrome with L-dopa. In operated and nonoperated cases]. Pimenta Ada M; Friguglietti DJ Rev Bras Med; 1971 Sep; 28(9):481-96. PubMed ID: 5139650 [No Abstract] [Full Text] [Related]
22. [Our first observations on Parkinson's disease or parkinsonian syndromes treated with L-dopa]. Boudouresques J; Khalil R; Vigouroux RA; Gosset A; Daniel F; Dufour H Mars Med; 1971; 108(2):85-9. PubMed ID: 5548385 [No Abstract] [Full Text] [Related]
23. Mental complications of L-dopa therapy in Parkinson's patients. Ginath Y; Lavy S; Abramsky O; Carmon A Isr Ann Psychiatr Relat Discip; 1971 Dec; 9(3):252-64. PubMed ID: 5291459 [No Abstract] [Full Text] [Related]
24. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature. Lewis I J Med Assoc State Ala; 1971 May; 40(11):709-18. PubMed ID: 5573008 [No Abstract] [Full Text] [Related]
25. Amino acid and dopa levels in plasma and urine from L-dopa-treated patients with Parkinson's disease. Hare TA; Vanna S; Beasley B; Chambers R; Vogel WH J Lab Clin Med; 1971 Feb; 77(2):319-25. PubMed ID: 5540775 [No Abstract] [Full Text] [Related]
26. [L-Dopa therapy in Parkinson's disease. A double-blind study]. Worm-Petersen J; Dupont E; Mikkelsen B Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651 [No Abstract] [Full Text] [Related]
27. [L-Dopa in the treatment of Parkinson's disease. (Considerations on 51 cases)]. Mazza C; Buffatti PF; Bazzan A; Lion P Fracastoro; 1970; 63(5):768-73. PubMed ID: 5519378 [No Abstract] [Full Text] [Related]
28. [Preliminary impressions of the therapeutic effectiveness of L-dopa in Parkinson's disease]. Buscaino GA; Campanella G Sist Nerv; 1970; 22(2):82-91. PubMed ID: 5504561 [No Abstract] [Full Text] [Related]
30. [Treatment of Parkinson's syndrome with L-dopa]. Kaeser HE; Ferel D; Wurmser P Schweiz Med Wochenschr; 1970 May; 100(19):805-13. PubMed ID: 4924276 [No Abstract] [Full Text] [Related]
31. [L-dopa and Parkinson's disease]. Barbeau A Union Med Can; 1970 Dec; 99(12):2195-7. PubMed ID: 5488646 [No Abstract] [Full Text] [Related]
32. An analysis of L-dopa-induced dyskinesias in 152 cases of Parkinson's disease. Mones RJ; Elizan TS; Siegel GJ Neurology; 1970 Apr; 20(4):405-6. PubMed ID: 5535050 [No Abstract] [Full Text] [Related]
33. [Therapy of Parkinson's syndrome with L-dopa per os combined with a decarboxylase inhibitor (Ro 46.02)]. Tissot R; Gaillard JM; Guggisberg M; Gauthier G; De Ajuriaguerra J Neurol Neurocir Psiquiatr; 1969; 10(1):1-25. PubMed ID: 5406970 [No Abstract] [Full Text] [Related]
34. [Use of L-DOPA in the therapy of parkinsonism]. D'Andrea F; De Divitiis E; Signorelli CD; Cerillo A; Tedeschi G Rass Int Clin Ter; 1971 Feb; 51(4):193-221. PubMed ID: 4930734 [No Abstract] [Full Text] [Related]
35. [L-dopa and parkinsonism. A preliminary report]. Pakkenberg H Ugeskr Laeger; 1969 May; 131(22):959-60. PubMed ID: 5793628 [No Abstract] [Full Text] [Related]